Pharma Reviews: 5 reasons why pharma stocks could still come under pressure

Six of the top eight Indian pharmaceutical companies derive more than 40 percent of their revenue from the USA. Not only is exports getting restricted, ...
Read more: 5 reasons why pharma stocks could still come under pressure